| PET/CT of esophageal cancer: its role in clinical management. | |
| | |
MedLine Citation:
|
PMID: 18025508 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Positron emission tomography (PET)/computed tomography (CT) has important utility and limitations in the initial staging of esophageal cancer, evaluation of response to neoadjuvant therapy, and detection of recurrent malignancy. Esophageal cancer is often treated by using a combined modality approach (chemotherapy, radiation therapy, and esophagectomy); correct integration of PET/CT into the conventional work-up of esophageal cancer requires a multidisciplinary approach that combines the information from PET/CT with results of clinical assessment, diagnostic CT, endoscopic gastroduodenoscopy, and endoscopic ultrasonography. PET/CT has limited utility in T staging of esophageal cancer and relatively limited utility in detection of dissemination to locoregional lymph nodes. However, PET/CT allows detection of metastatic disease that may not be identifiable with other methods. PET/CT is not sufficiently reliable in the individual patient for determination of treatment response in the primary tumor. Interpretation of PET/CT results is optimized by understanding the diagnostic limitations and pitfalls that may be encountered, together with knowledge of the natural history of esophageal cancer and the staging and treatment options available. |
| | |
Authors:
|
John F Bruzzi; Reginald F Munden; Mylene T Truong; Edith M Marom; Bradley S Sabloff; Gregory W Gladish; Revathy B Iyer; Tin-Su Pan; Homer A Macapinlac; Jeremy J Erasmus |
Related Documents
:
|
17428168 - Is 18f fdg pet-ct cost effective in lung cancer? 17059628 - Should fdg-pet scanning be routinely used for patients with an unknown head and neck sq... 17414758 - [f-18]fluorodeoxyglucose positron emission tomography and positron emission tomography:... 12442918 - Positron emission tomography for the staging of hodgkin's lymphoma--increasing the body... 10554998 - Sulcal variability of twins. 19380068 - Human fetal brain chemistry as detected by proton magnetic resonance spectroscopy. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Radiographics : a review publication of the Radiological Society of North America, Inc Volume: 27 ISSN: 1527-1323 ISO Abbreviation: Radiographics Publication Date: 2007 Nov-Dec |
Date Detail:
|
Created Date: 2007-11-20 Completed Date: 2008-01-18 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8302501 Medline TA: Radiographics Country: United States |
Other Details:
|
Languages: eng Pagination: 1635-52 Citation Subset: IM |
Copyright Information:
|
RSNA, 2007 |
Affiliation:
|
Division of Diagnostic Imaging, M. D. Anderson Cancer Center, Houston, Tex, USA. bruzzij@hotmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenocarcinoma
/
diagnosis*,
pathology,
secondary,
therapy Artifacts Brain Neoplasms / secondary Colonic Neoplasms / secondary Esophageal Neoplasms / diagnosis*, pathology, therapy False Positive Reactions Humans Lymphatic Metastasis Neoplasm Invasiveness Neoplasm Staging Positron-Emission Tomography / methods* Sensitivity and Specificity Tomography, X-Ray Computed / methods* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies...
Next Document: Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT.